The recent disruptions in global supply have highlighted the value of securing vital medications like Ivermectin. Trusting on overseas manufacturers exposes countries to considerable vulnerabilities, including shipping delays, price fluctuations, and even geopolitical threats. Moving towards domestic production of Ivermectin offers a multitude of a